# IBRANCE
> **NDA207103** · New Drug Application · Sponsor: PFIZER · Approved 2015-02-03
## Drug
- **FDA Application Number:** NDA207103
- **Application type:** New Drug Application
- **Brand name:** IBRANCE
- **Generic name:** PALBOCICLIB
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2015-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207103)
---
*AI Analytics · CC0 1.0*